Approved trends and product characteristics of digital therapeutics in four countries

Approved trends and product characteristics of digital therapeutics in four countries

Abstract Digital therapeutics (DTx) provide innovative treatment options. In this study, we identified and compared approved DTx in China, the US, Germany, and Belgium. In total, 507 DTx applications were identified (US, 192; China, 235; Germany, 55; Belgium, 25). China has approved the most, wherea...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Liang, Qichuan Fang, Xiaoyi Jiao, Peng Xiang, Junhao Ma, Zijiao Zhang, Yongcheng Liu, Yunfan He, Yingjun Li, Zhixu He, Jianbo Lei
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-025-01660-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items